The effect of the CCR5-delta32 deletion on global gene expression considering immune response and inflammation

Journal of Inflammation

Volumn 8, Issue , 2011, Pages

  Hütter, Gero ^a   Neumann, Martin ^b   Nowak, Daniel ^c   Klein, Stefan ^c   Klüter, Harald ^a   Hofmann, Wolf K ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

CCR5 delat32; Chemokine; Graft versus host disease; transplantation

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ADULT; AGED; ARTICLE; CCR5 DELTA32 GENE; CCRL2 GENE; CD30L GENE; CD6 GENE; CD7 GENE; CHROMOSOME 3; CONTROLLED STUDY; CXCR2 GENE; FEMALE; GENE; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HOMOZYGOSITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; LRG1 GENE; MALE; MICROARRAY ANALYSIS; NORMAL HUMAN; POLYMERASE CHAIN REACTION; WD REPEAT DOMAIN GENE;

EID: 83155176150     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-8-29     Document Type: Article

References (57)

1. Chemokine: receptor structure, interactions, and antagonism. Allen SJ, Crown SE, Handel TM, Annu Rev Immunol 2007 25 787 820 10.1146/annurev.immunol. 24.021605.090529 17291188 (Pubitemid 46697924)
2. Chemokine receptor CCR5: insights into structure, function, and regulation. Oppermann M, Cell Signal 2004 16 1201 1210 10.1016/j.cellsig.2004. 04.007 15337520 (Pubitemid 39165449)
3. The biology of chemokines and their receptors. Rossi D, Zlotnik A, Annu Rev Immunol 2000 18 217 242 10.1146/annurev.immunol.18.1.217 10837058 (Pubitemid 30365380)
4. G protein-coupled receptor sorting to endosomes and lysosomes. Marchese A, Paing MM, Temple BR, Trejo J, Annu Rev Pharmacol Toxicol 2008 48 601 629 10.1146/annurev.pharmtox.48.113006.094646 17995450 (Pubitemid 351738165)
5. CCR5 promoter alleles and specific DNA binding factors. Bream JH, Young HA, Rice N, Martin MP, Smith MW, Carrington M, O'Brien SJ, Science 1999 284 223 10.1126/science.284.5412.223a 15224670
6. Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences. Carrington M, Dean M, Martin MP, O'Brien SJ, Hum Mol Genet 1999 8 1939 1945 10.1093/hmg/8.10.1939 10469847 (Pubitemid 29458672)
7. ENSEMBL, http://www.ensembl.org
8. Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Stephens JC, Reich DE, Goldstein DB, Shin HD, Smith MW, Carrington M, Winkler C, Huttley GA, Allikmets R, Schriml L, et al. Am J Hum Genet 1998 62 1507 1515 10.1086/301867 9585595 (Pubitemid 28307122)
9. The evolutionary history of the CCR5-Delta32 HIV-resistance mutation. Galvani AP, Novembre J, Microbes Infect 2005 7 302 309 10.1016/j.micinf.2004.12. 006 15715976 (Pubitemid 40387436)
10. CCR5: no longer a "good for nothing" gene - chemokine control of West Nile virus infection. Lim JK, Glass WG, McDermott DH, Murphy PM, Trends Immunol 2006 27 308 312 10.1016/j.it.2006.05.007 16753343 (Pubitemid 43963479)
11. Chemokines and transplant immunobiology. Hancock WW, J Am Soc Nephrol 2002 13 821 824 11856791 (Pubitemid 34183952)
12. CCR5 blockade modulates inflammation and alloimmunity in primates. Schroder C, Pierson RN, Nguyen BN, Kawka DW, Peterson LB, Wu G, Zhang T, Springer MS, Siciliano SJ, Iliff S, et al. J Immunol 2007 179 2289 2299 17675490
13. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A. Li J, Xia J, Zhang K, Xu L, J Surg Res 2009 157 81 90 10.1016/j.jss.2009.01.014 19577762
14. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, et al. Nature 1996 382 722 725 10.1038/382722a0 8751444 (Pubitemid 26282179)
15. Functional analysis of the proximal CCR5 promoter. Liu R, Zhao X, Gurney TA, Landau NR, AIDS Res Hum Retroviruses 1998 14 1509 1519 10.1089/aid.1998.14. 1509 9840284 (Pubitemid 28527795)
16. CC chemokine receptor 5 gene promoter activation by the cyclic AMP response element binding transcription factor. Kuipers HF, Biesta PJ, Montagne LJ, van Haastert ES, van der Valk P, van den Elsen PJ, Blood 2008 112 1610 1619 10.1182/blood-2008-01-135111 18511806
17. The biology of CCR5 and CXCR4. Alkhatib G, Curr Opin HIV AIDS 2009 4 96 103 10.1097/COH.0b013e328324bbec 19339947
18. CC chemokine receptor 5 and renal-transplant survival. Fischereder M, Luckow B, Hocher B, Wuthrich RP, Rothenpieler U, Schneeberger H, Panzer U, Stahl RA, Hauser IA, Budde K, et al. Lancet 2001 357 1758 1761 10.1016/S0140-6736(00) 04898-4 11403814 (Pubitemid 32524207)
19. CCR5 deletion mutation and its association with the risk of developing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bogunia-Kubik K, Duda D, Suchnicki K, Lange A, Haematologica 2006 91 1628 1634 17145599 (Pubitemid 46032960)
20. Immunobiology of acute graft-versus-host disease. Reddy P, Ferrara JL, Blood Rev 2003 17 187 194 10.1016/S0268-960X(03)00009-2 14556773 (Pubitemid 37356389)
21. Role of HLA in hematopoietic SCT. Nowak J, Bone Marrow Transplant 2008 42 Suppl 2 71 76 18978750
22. Management of acute graft versus host disease (GvHD). Bacigalupo A, Palandri F, Hematol J 2004 5 189 196 10.1038/sj.thj.6200399 15167903 (Pubitemid 38937019)
23. Beneficial effects of targeting CCR5 in allograft recipients. Gao W, Faia KL, Csizmadia V, Smiley ST, Soler D, King JA, Danoff TM, Hancock WW, Transplantation 2001 72 1199 1205 10.1097/00007890-200110150-00003 11602842 (Pubitemid 33026595)
24. Chemokine receptor blockade with a synthetic nonpeptide compound attenuates cardiac allograft vasculopathy. Bastani S, Sherman W, Schnickel GT, Hsieh GR, Bhatia R, Fishbein MC, Ardehali A, Transplantation 2009 88 995 1001 10.1097/TP.0b013e3181b9ccd5 19855245
25. Combined treatment with chemokine receptor 5 blocker and cyclosporine induces prolonged graft survival in a mouse model of cardiac transplantation. Jun L, Kailun Z, Aini X, Lei X, Guohua W, Sihua W, Ping Y, Tucheng S, Xionggang J, Wenwei C, Jiahong X, J Heart Lung Transplant 2010 29 461 470 10.1016/j.healun.2009.09.019 20060322
26. De novo deletion within the telomeric region flanking the human alpha globin locus as a cause of alpha thalassaemia. Viprakasit V, Kidd AM, Ayyub H, Horsley S, Hughes J, Higgs DR, Br J Haematol 2003 120 867 875 10.1046/j.1365-2141.2003.04197.x 12614224 (Pubitemid 36315113)
27. Deletions of 16q in Wilms tumors localize to blastemal-anaplastic cells and are associated with reduced expression of the IRXB renal tubulogenesis gene cluster. Mengelbier LH, Karlsson J, Lindgren D, Ora I, Isaksson M, Frigyesi I, Frigyesi A, Bras J, Sandstedt B, Gisselsson D, Am J Pathol 2010 177 2609 2621 10.2353/ajpath.2010.100130 20847289
28. The genes encoding the human CC-chemokine receptors CC-CKR1 to CC-CKR5 (CMKBR1-CMKBR5) are clustered in the p21.3-p24 region of chromosome 3. Samson M, Soularue P, Vassart G, Parmentier M, Genomics 1996 36 522 526 10.1006/geno.1996.0498 8884276 (Pubitemid 26321975)
29. Mapping of the CCXCR1, CX3CR1, CCBP2 and CCR9 genes to the CCR cluster within the 3p21.3 region of the human genome. Maho A, Bensimon A, Vassart G, Parmentier M, Cytogenet Cell Genet 1999 87 265 268 10.1159/000015443 10702689 (Pubitemid 30103110)
30. Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Hofmann WK, de Vos S, Komor M, Hoelzer D, Wachsman W, Koeffler HP, Blood 2002 100 3553 3560 10.1182/blood.V100.10.3553 12411319 (Pubitemid 35303923)
31. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, et al. Nat Genet 2001 29 365 371 10.1038/ng1201-365 11726920 (Pubitemid 34326681)
32. Minimum Information About a Microarray Experiment (MIAME) - successes, failures, challenges. Brazma A, ScientificWorldJournal 2009 9 420 423 19484163
33. Donor and recipient chemokine receptor CCR5 genotype is associated with survival after bone marrow transplantation. McDermott DH, Conway SE, Wang T, Ricklefs SM, Agovi MA, Porcella SF, Tran HT, Milford E, Spellman S, Abdi R, Blood 2010 115 2311 2318 10.1182/blood-2009-08-237768 20068218
34. Up-regulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response. Shirai R, Hirano F, Ohkura N, Ikeda K, Inoue S, Biochem Biophys Res Commun 2009 382 776 779 10.1016/j.bbrc.2009.03.104 19324010
35. Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation. O'Donnell LC, Druhan LJ, Avalos BR, J Leukoc Biol 2002 72 478 485 12223515
36. Association of polymorphisms of interleukin-8, CXCR1, CXCR2, and selectin with allograft outcomes in kidney transplantation. Ro H, Hwang YH, Kim H, Jeong JC, Lee H, Doh YS, Park HC, Oh KH, Park MH, Ha J, et al. Transplantation 2011 91 57 64 10.1097/TP.0b013e3181fd0195 21452410
37. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response. Pellegrini P, Berghella AM, Contasta I, Adorno D, Transpl Immunol 2003 12 49 61 10.1016/S0966-3274(03)00014-5 14551032
38. CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease. Blazar BR, Levy RB, Mak TW, Panoskaltsis-Mortari A, Muta H, Jones M, Roskos M, Serody JS, Yagita H, Podack ER, Taylor PA, J Immunol 2004 173 2933 2941 15322151 (Pubitemid 39141997)
39. Deciphering CD30 ligand biology and its role in humoral immunity. Kennedy MK, Willis CR, Armitage RJ, Immunology 2006 118 143 152 10.1111/j.1365-2567. 2006.02354.x 16771849 (Pubitemid 43727419)
40. CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism. Dai Z, Li Q, Wang Y, Gao G, Diggs LS, Tellides G, Lakkis FG, J Clin Invest 2004 113 310 317 14722622 (Pubitemid 38544215)
41. NKT cells, Treg, and their interactions in bone marrow transplantation. Kohrt HE, Pillai AB, Lowsky R, Strober S, Eur J Immunol 40 1862 1869
42. Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthropathies. Vargas-Alarcon G, Londono JD, Hernandez-Pacheco G, Gamboa R, Castillo E, Pacheco-Tena C, Cardiel MH, Granados J, Burgos-Vargas R, Ann Rheum Dis 2002 61 48 51 10.1136/ard.61.1.48 11779758 (Pubitemid 34074839)
43. Heat shock protein 70 gene polymorphism in Japanese patients with multiple sclerosis. Niino M, Kikuchi S, Fukazawa T, Yabe I, Sasaki H, Tashiro K, Tissue Antigens 2001 58 93 96 10.1034/j.1399-0039.2001.580205.x 11696222 (Pubitemid 33020623)
44. CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation. Marcos V, Zhou Z, Yildirim AO, Bohla A, Hector A, Vitkov L, Wiedenbauer EM, Krautgartner WD, Stoiber W, Belohradsky BH, et al. Nat Med 2010 16 1018 1023 10.1038/nm.2209 20818377
45. Anti-inflammatory heat shock protein 70 genes are positively associated with human survival. Singh R, Kolvraa S, Bross P, Christensen K, Bathum L, Gregersen N, Tan Q, Rattan SI, Curr Pharm Des 16 796 801
46. Up-regulated expression and activation of the orphan chemokine receptor, CCRL2, in rheumatoid arthritis. Galligan CL, Matsuyama W, Matsukawa A, Mizuta H, Hodge DR, Howard OM, Yoshimura T, Arthritis Rheum 2004 50 1806 1814 10.1002/art.20275 15188357 (Pubitemid 38725093)
47. A novel SR-related protein is required for the second step of Pre-mRNA splicing. Cazalla D, Newton K, Caceres JF, Mol Cell Biol 2005 25 2969 2980 10.1128/MCB.25.8.2969-2980.2005 15798186 (Pubitemid 40464302)
48. Human CD6 possesses a large, alternatively spliced cytoplasmic domain. Robinson WH, Neuman de Vegvar HE, Prohaska SS, Rhee JW, Parnes JR, Eur J Immunol 1995 25 2765 2769 10.1002/eji.1830251008 7589069
49. Human intrathymic lineage commitment is marked by differential CD7 expression: identification of CD7- lympho-myeloid thymic progenitors. Hao QL, George AA, Zhu J, Barsky L, Zielinska E, Wang X, Price M, Ge S, Crooks GM, Blood 2008 111 1318 1326 17959857 (Pubitemid 351213418)
50. Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease. Zeiser R, Nguyen VH, Hou JZ, Beilhack A, Zambricki E, Buess M, Contag CH, Negrin RS, Blood 2007 109 2225 2233 10.1182/blood-2006-07-038455 17068147 (Pubitemid 46348227)
51. Transcription of the beta-galactoside alpha2,6-sialyltransferase gene (SIAT1) in B-lymphocytes: cell type-specific expression correlates with presence of the divergent 5'-untranslated sequence. Lo NW, Lau JT, Glycobiology 1999 9 907 914 10.1093/glycob/9.9.907 10460832 (Pubitemid 29435864)
52. Physical interaction between aldolase and vacuolar H+-ATPase is essential for the assembly and activity of the proton pump. Lu M, Ammar D, Ives H, Albrecht F, Gluck SL, J Biol Chem 2007 282 24495 24503 10.1074/jbc.M702598200 17576770 (Pubitemid 47347536)
53. Association of LKB1 with a WD-repeat protein WDR6 is implicated in cell growth arrest and p27(Kip1) induction. Xie X, Wang Z, Chen Y, Mol Cell Biochem 2007 301 115 122 10.1007/s11010-006-9402-5 17216128 (Pubitemid 46895151)
54. CCR5 expression on cells from HLA-matched unrelated marrow donors and graft-versus-host disease. Ma Q, Gooley TA, Storb RF, Biol Blood Marrow Transplant 2010 16 132 133 10.1016/j.bbmt.2009.05.017 20053336
55. Chemokine receptor 5Delta32 mutation reduces the risk of acute rejection in liver transplantation. Heidenhain C, Puhl G, Moench C, Lautem A, Neuhaus P, Ann Transplant 2009 14 36 44 19644158
56. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. Abdi R, Tran TB, Sahagun-Ruiz A, Murphy PM, Brenner BM, Milford EL, McDermott DH, J Am Soc Nephrol 2002 13 754 758 11856781 (Pubitemid 34183942)
57. CCR5, RANTES and CX3CR1 polymorphisms: possible genetic links with acute heart rejection. Simeoni E, Vassalli G, Seydoux C, Ramsay D, Noll G, von Segesser LK, Fleury S, Transplantation 2005 80 1309 1315 10.1097/01.tp. 0000178378.53616.ca 16314800 (Pubitemid 41746810)